Omega Healthcare Investors (NYSE:OHI) Rating Lowered to “Equal Weight” at Wells Fargo & Company

Omega Healthcare Investors (NYSE:OHI) was downgraded by investment analysts at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating in a research note issued on Thursday,Finviz reports. They currently have a $45.00 price objective on the real estate investment trust’s stock. Wells Fargo & Company‘s price objective indicates a potential upside of 4.15% from the stock’s current price.

A number of other equities analysts have also weighed in on OHI. Cantor Fitzgerald initiated coverage on shares of Omega Healthcare Investors in a research note on Wednesday, October 1st. They issued an “overweight” rating and a $50.00 target price for the company. Weiss Ratings upgraded Omega Healthcare Investors from a “buy (b+)” rating to a “buy (a-)” rating in a report on Monday. Scotiabank lifted their target price on Omega Healthcare Investors from $42.00 to $45.00 and gave the company a “sector perform” rating in a research report on Thursday, November 13th. BMO Capital Markets downgraded Omega Healthcare Investors from an “outperform” rating to a “market perform” rating and set a $45.00 price target for the company. in a research report on Friday, January 9th. Finally, UBS Group lifted their price objective on shares of Omega Healthcare Investors from $50.00 to $51.00 and gave the company a “buy” rating in a report on Thursday, January 8th. One investment analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating and eight have given a Hold rating to the stock. Based on data from MarketBeat, Omega Healthcare Investors has an average rating of “Moderate Buy” and an average price target of $46.82.

Omega Healthcare Investors Stock Performance

Shares of OHI stock opened at $43.21 on Thursday. The company has a debt-to-equity ratio of 0.95, a quick ratio of 7.11 and a current ratio of 7.11. Omega Healthcare Investors has a 52 week low of $35.04 and a 52 week high of $46.36. The company’s 50 day moving average price is $44.63 and its two-hundred day moving average price is $42.40. The company has a market capitalization of $12.77 billion, a P/E ratio of 24.14, a price-to-earnings-growth ratio of 1.39 and a beta of 0.57.

Omega Healthcare Investors (NYSE:OHI) last released its quarterly earnings results on Thursday, October 30th. The real estate investment trust reported $0.79 earnings per share for the quarter, beating the consensus estimate of $0.77 by $0.02. Omega Healthcare Investors had a net margin of 46.83% and a return on equity of 10.72%. The company had revenue of $311.59 million during the quarter, compared to analysts’ expectations of $262.48 million. During the same quarter in the prior year, the company earned $0.71 earnings per share. The business’s quarterly revenue was up 14.4% compared to the same quarter last year. On average, analysts expect that Omega Healthcare Investors will post 2.86 earnings per share for the current fiscal year.

Insider Activity at Omega Healthcare Investors

In related news, CEO C Taylor Pickett acquired 20,000 shares of the company’s stock in a transaction dated Wednesday, November 5th. The shares were bought at an average price of $43.14 per share, for a total transaction of $862,800.00. Following the purchase, the chief executive officer directly owned 20,000 shares in the company, valued at approximately $862,800. This trade represents a ? increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, CIO Vikas Gupta bought 11,500 shares of the firm’s stock in a transaction that occurred on Thursday, November 6th. The stock was purchased at an average cost of $42.97 per share, with a total value of $494,155.00. Following the completion of the purchase, the executive directly owned 13,773 shares of the company’s stock, valued at $591,825.81. This represents a 505.94% increase in their position. The SEC filing for this purchase provides additional information. 1.50% of the stock is owned by insiders.

Institutional Investors Weigh In On Omega Healthcare Investors

Institutional investors and hedge funds have recently modified their holdings of the company. Royal Bank of Canada increased its position in Omega Healthcare Investors by 29.4% during the first quarter. Royal Bank of Canada now owns 144,339 shares of the real estate investment trust’s stock worth $5,496,000 after buying an additional 32,798 shares during the last quarter. Focus Partners Wealth increased its holdings in shares of Omega Healthcare Investors by 3.1% during the 1st quarter. Focus Partners Wealth now owns 19,862 shares of the real estate investment trust’s stock worth $756,000 after acquiring an additional 597 shares during the last quarter. Sivia Capital Partners LLC bought a new stake in Omega Healthcare Investors in the 2nd quarter valued at $257,000. Farther Finance Advisors LLC raised its stake in Omega Healthcare Investors by 7.1% in the 2nd quarter. Farther Finance Advisors LLC now owns 4,182 shares of the real estate investment trust’s stock valued at $153,000 after acquiring an additional 279 shares during the period. Finally, Trust Co. of Vermont acquired a new stake in Omega Healthcare Investors during the 2nd quarter valued at $95,000. 65.25% of the stock is owned by institutional investors.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.